Heart failure (HF) is a significant cause of morbidity and mortality worldwide. Circulating
biomarkers reflecting pathophysiological pathways involved in HF development and …

New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

Despite the enhanced knowledge of the pathophysiology of heart failure (HF), it still remains
a serious syndrome with substantial morbidity, mortality, and frequent hospitalizations …

Heart failure is a clinical condition with complex pathophysiology that involves many
different processes. Diagnosis is often difficult in patients presenting for the first time with …

Background An overview of the diagnostic performance of natriuretic peptides (NPs) for the
detection of diastolic dysfunction (DD) and heart failure with preserved ejection fraction …

The prevalence of heart failure with preserved ejection fraction (HFpEF) is steadily
increasing. Its diagnosis remains difficult and controversial and relies mostly on non …

Aims How often a medical article is cited is important for many people because it is used to
calculate different variables such as the h‐index and the journal impact factor. The aim of …

Circulating proteins may provide insights into the varying biological mechanisms involved in
heart failure (HF) with preserved ejection fraction (HFpEF) and reduced ejection fraction …

Abstract Heart failure affects 2–3% of adult Western population. Prevalence of heart failure
with preserved left ventricular (LV) ejection fraction (HFpEF) increases. Studies suggest …

Aim Diagnosing heart failure with preserved ejection fraction (HFpEF) in the non‐acute
setting remains challenging. Natriuretic peptides have limited value for this purpose, and a …